Cargando…
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer
BACKGROUND: In clinical practice alterations in CA-125 concentration within normal range in patients with ovarian cancer after first-line treatment are common. Even minor increase in CA-125 concentration is associated with patients’ anxiety and difficult interpretation and counselling for clinicians...
Autores principales: | Piatek, Szymon, Panek, Grzegorz, Lewandowski, Zbigniew, Bidzinski, Mariusz, Piatek, Dominika, Kosinski, Przemyslaw, Wielgos, Miroslaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469284/ https://www.ncbi.nlm.nih.gov/pubmed/32878632 http://dx.doi.org/10.1186/s13048-020-00681-0 |
Ejemplares similares
-
Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2021) -
Reproductive Results in Cancer Survivors after Fertility Sparing Management: The Need for the Standardization of Definitions
por: Piątek, Szymon, et al.
Publicado: (2023) -
Fertility-Sparing Management May Be Considered in Young Women with Uterine Sarcoma
por: Piątek, Szymon, et al.
Publicado: (2022) -
Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
por: Piątek, Szymon, et al.
Publicado: (2023) -
Assessment of Hospital Volume in the Surgical Management of Endometrial and Ovarian Cancer: A Polish Population-Based Study
por: Piątek, Szymon, et al.
Publicado: (2023)